The researchers said these marked improvements are probably a “direct consequence” of new practices that followed updated guidelines from key organizations of heart doctors in the United States and Europe.
Recommendations in those guidelines include quick use of aspirin or more potent blood thinners; beta blockers to reduce the damaged heart’s oxygen needs, statins to lower cholesterol; ACE inhibitors to relax blood vessels; and angioplasty to open blocked vessels soon after hospital arrival. 85 percent of heart patients studied got cholesterol drugs in 2005 versus just 37 percent in 1999; 78 percent got potent blood thinners including Plavix versus 30 percent in 1999; and 53 percent had quick angioplasty, compared to just 16 percent six years earlier.
This is related to an earlier article that bodily cell, organs and tissue rejuvenation combined with the elimination of 50% of deaths from disease would lead to lifespans of 151 years. 90% disease elimination and successful rejuvenation therapies would lead to lifespans of 512 years.
Robert Freitas has finished his latest theoretical scaling study of a new diamondoid medical nanorobot called the “chromallocyte”. This is the first full technical description of a cell repair nanorobot ever published.